NL1012300C2 - Stabilisator voor farmaca. - Google Patents

Stabilisator voor farmaca. Download PDF

Info

Publication number
NL1012300C2
NL1012300C2 NL1012300A NL1012300A NL1012300C2 NL 1012300 C2 NL1012300 C2 NL 1012300C2 NL 1012300 A NL1012300 A NL 1012300A NL 1012300 A NL1012300 A NL 1012300A NL 1012300 C2 NL1012300 C2 NL 1012300C2
Authority
NL
Netherlands
Prior art keywords
inulin
pharmacon
fructan
sugar
glass
Prior art date
Application number
NL1012300A
Other languages
English (en)
Dutch (nl)
Inventor
Hendrik Willem Frijlink
Wouter Leonardus Jose Hinrichs
Original Assignee
Rijksuniversiteit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit filed Critical Rijksuniversiteit
Priority to NL1012300A priority Critical patent/NL1012300C2/nl
Priority to CA002375241A priority patent/CA2375241C/en
Priority to DE60001744T priority patent/DE60001744T2/de
Priority to AU55797/00A priority patent/AU5579700A/en
Priority to EP00941031A priority patent/EP1194453B1/de
Priority to PCT/NL2000/000405 priority patent/WO2000078817A1/en
Priority to AT00941031T priority patent/ATE234868T1/de
Application granted granted Critical
Publication of NL1012300C2 publication Critical patent/NL1012300C2/nl
Priority to US10/007,800 priority patent/US6841169B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • C08B37/0054—Inulin, i.e. beta-2,1-D-fructofuranan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL1012300A 1999-06-11 1999-06-11 Stabilisator voor farmaca. NL1012300C2 (nl)

Priority Applications (8)

Application Number Priority Date Filing Date Title
NL1012300A NL1012300C2 (nl) 1999-06-11 1999-06-11 Stabilisator voor farmaca.
CA002375241A CA2375241C (en) 1999-06-11 2000-06-13 Stabilizer for pharmacons
DE60001744T DE60001744T2 (de) 1999-06-11 2000-06-13 Stabilisator für arzneimittel
AU55797/00A AU5579700A (en) 1999-06-11 2000-06-13 Stabilizer for pharmacons
EP00941031A EP1194453B1 (de) 1999-06-11 2000-06-13 Stabilisator für arzneimittel
PCT/NL2000/000405 WO2000078817A1 (en) 1999-06-11 2000-06-13 Stabilizer for pharmacons
AT00941031T ATE234868T1 (de) 1999-06-11 2000-06-13 Stabilisator für arzneimittel
US10/007,800 US6841169B2 (en) 1999-06-11 2001-12-07 Stabilizer for pharmacons

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1012300 1999-06-11
NL1012300A NL1012300C2 (nl) 1999-06-11 1999-06-11 Stabilisator voor farmaca.

Publications (1)

Publication Number Publication Date
NL1012300C2 true NL1012300C2 (nl) 2000-12-12

Family

ID=19769360

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1012300A NL1012300C2 (nl) 1999-06-11 1999-06-11 Stabilisator voor farmaca.

Country Status (8)

Country Link
US (1) US6841169B2 (de)
EP (1) EP1194453B1 (de)
AT (1) ATE234868T1 (de)
AU (1) AU5579700A (de)
CA (1) CA2375241C (de)
DE (1) DE60001744T2 (de)
NL (1) NL1012300C2 (de)
WO (1) WO2000078817A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
SG114553A1 (en) * 2001-06-29 2005-09-28 Seagate Technology Llc Systems, apparatus, and methods to determine thermal decay characterization from an equalized signal-to-noise ratio of a magnetic disc drive device
ES2316759T3 (es) * 2002-04-03 2009-04-16 Solvay Pharmaceuticals B.V. Formulacion de cannabinoide natural estabilizada.
EP1428526A1 (de) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Zusammensetzung zur schnellen Freisetzung von lipophilen Stoffen
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
BRPI0512839A (pt) * 2004-07-01 2008-04-08 3M Innovative Properties Co método de proteção de uma superfìcie de piso, superfìcie de piso, material de piso, e, composição de revestimento duro
TW200621310A (en) * 2004-11-10 2006-07-01 Univ Groningen A process for preparing formulations of lypophilic active substances by spray freeze drying
US20070098864A1 (en) * 2004-11-10 2007-05-03 Zijlstra Gerrit S Process for preparing formulations of lypophilic active substances by spray freezing drying
JP4870944B2 (ja) * 2005-05-23 2012-02-08 弘 竹田 眼薬用組成物
CA2719064C (en) 2008-04-23 2014-02-18 Kim Martha Jozefa Frooninckx Aqueous dispersion of fructan-containing particles, method of preparation and use
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
ES2643087T3 (es) * 2010-03-29 2017-11-21 Ferring B.V. Composición farmacéutica de disolución rápida
WO2013037708A1 (en) * 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition
US11116745B2 (en) * 2018-01-31 2021-09-14 Deep Cell Industries, Inc. Prebiotic formulation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383569A2 (de) * 1989-02-16 1990-08-22 Pafra Limited Lagerung von Materialien
EP0437622A1 (de) * 1989-07-07 1991-07-24 Kyowa Hakko Kogyo Co., Ltd. Beständige motilin-herstellung
WO1996005809A1 (en) * 1994-08-19 1996-02-29 Quadrant Holdings Cambridge Limited Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61181960A (ja) * 1985-02-06 1986-08-14 Daicel Chem Ind Ltd 複合構造物
JP2780361B2 (ja) 1989-08-07 1998-07-30 三井化学株式会社 剥離性保護フィルムおよびその組成物
US5250429A (en) * 1991-09-20 1993-10-05 Pharmacia P-L Biochemicals Inc. Glassified restriction enzymes
JP3509148B2 (ja) * 1993-10-07 2004-03-22 明治製菓株式会社 凍害保護剤および凍結保存方法
US6455068B1 (en) * 1995-12-26 2002-09-24 Onesta Nutrition, Inc. Dietary fiber delivery system
EP0879600A1 (de) * 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383569A2 (de) * 1989-02-16 1990-08-22 Pafra Limited Lagerung von Materialien
EP0437622A1 (de) * 1989-07-07 1991-07-24 Kyowa Hakko Kogyo Co., Ltd. Beständige motilin-herstellung
WO1996005809A1 (en) * 1994-08-19 1996-02-29 Quadrant Holdings Cambridge Limited Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof

Also Published As

Publication number Publication date
ATE234868T1 (de) 2003-04-15
DE60001744D1 (de) 2003-04-24
CA2375241A1 (en) 2000-12-28
AU5579700A (en) 2001-01-09
WO2000078817A1 (en) 2000-12-28
DE60001744T2 (de) 2004-03-18
US20020122825A1 (en) 2002-09-05
EP1194453A1 (de) 2002-04-10
US6841169B2 (en) 2005-01-11
CA2375241C (en) 2009-12-22
EP1194453B1 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
NL1012300C2 (nl) Stabilisator voor farmaca.
AU710039B2 (en) Compositions in glassy phase, stabilised by a sugar
Mensink et al. Inulin, a flexible oligosaccharide. II: Review of its pharmaceutical applications
JP5137579B2 (ja) 噴霧凍結乾燥により脂肪親和性活性物質の製剤を製造する方法
Hinrichs et al. Inulin glasses for the stabilization of therapeutic proteins
KR100777349B1 (ko) 민감한 생물학적 물질의 보존방법
EP1492503B1 (de) Stabilisierte natürliche cannabinoid formulierung
JPH02265984A (ja) 物質の貯蔵
Bajpai et al. Dynamics of controlled release of heparin from swellable crosslinked starch microspheres
US20070098864A1 (en) Process for preparing formulations of lypophilic active substances by spray freezing drying
US5902844A (en) Spray drying of pharmaceutical formulations containing amino acid-based materials
RU2225709C2 (ru) Лиофилизат с улучшенной восстанавливаемостью в исходное состояние (варианты), способ его получения и фармацевтический препарат
CN101125124B (zh) 一种亲脂性药物固体分散体的制备方法
KR100976073B1 (ko) 안정화된 천연 칸나비노이드 제형
IL163936A (en) Stabilized natural cannabinoid formulation
Mensink et al. ΖQXOLQ D ȵH [LEOH oligosaccharide II: Review of its pharmaceutical applications

Legal Events

Date Code Title Description
PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20070101